Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-09-26 Purchase | 2025-10-01 10:40 am | Drugs Made In America Acquisition II Corp. | DMII | Stockwell Lynn CEO and Exe. Chair of Board 10% Owner | 700,000 | $0 | $0 | 7,808,333 (Indirect) | View |
| 2025-09-26 Sale | 2025-10-01 10:40 am | Drugs Made In America Acquisition II Corp. | DMII | Stockwell Lynn CEO and Exe. Chair of Board 10% Owner | 7,966,667 | $0 | $0 | 7,808,333 (Indirect) | View |
| 2025-09-26 Purchase | 2025-10-01 10:37 am | Drugs Made In America Acquisition II Corp. | DMII | Drugs Made In America Acquisition II LLC 10% Owner | 700,000 | $0 | $0 | 7,808,333 (Direct) | View |
| 2025-09-26 Sale | 2025-10-01 10:37 am | Drugs Made In America Acquisition II Corp. | DMII | Drugs Made In America Acquisition II LLC 10% Owner | 7,966,667 | $0 | $0 | 7,808,333 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-09-26 Other | 2025-10-17 12:51 pm | N/A N/A | Drugs Made In America Acquisition II Corp. | DMII | Do Catherine Director | 100,000 | $0 | 200,000 (Direct) | View |
| 2025-09-26 Other | 2025-10-02 2:51 pm | N/A N/A | Drugs Made In America Acquisition II Corp. | DMII | Shulgan Myron W. Director | 100,000 | $0 | 200,000 (Direct) | View |
| 2025-09-26 Other | 2025-10-01 3:49 pm | N/A N/A | Drugs Made In America Acquisition II Corp. | DMII | Worman Glenn C. CFO | 100,000 | $0 | 200,000 (Direct) | View |
| 2025-09-26 Other | 2025-10-01 10:40 am | N/A N/A | Drugs Made In America Acquisition II Corp. | DMII | Stockwell Lynn CEO and Exe. Chair of Board 10% Owner | 400,000 | $0 | 7,808,333 (Indirect) | View |
| 2025-09-26 Other | 2025-10-01 10:37 am | N/A N/A | Drugs Made In America Acquisition II Corp. | DMII | Drugs Made In America Acquisition II LLC 10% Owner | 400,000 | $0 | 7,808,333 (Direct) | View |
| 2025-09-26 Other | 2025-10-01 10:34 am | N/A N/A | Drugs Made In America Acquisition II Corp. | DMII | Prasad Sridhar G. Director | 100,000 | $0 | 200,000 (Direct) | View |
Ownership | 2025-09-25 8:43 pm | N/A N/A | Drugs Made In America Acquisition II Corp. | DMII | Drugs Made In America Acquisition II LLC 10% Owner | 0 | $0 | 14,375,000 (Direct) | View |
Ownership | 2025-09-24 5:43 pm | N/A N/A | Drugs Made In America Acquisition II Corp. | DMII | Stockwell Lynn CEO & Exe. Chair of the Board 10% Owner | 0 | $0 | 14,375,000 (Indirect) | View |